🎯 check Lazertinib (YH25448) product page
Lazertinib (YH25448) is a kinase inhibitor. It affects cMET signaling, by reducing cMET receptor density, to promote ADCC.
Lazertinib (YH25448) Mechanism of Action: EGFR Inhibition in Non-Small Cell Lung Cancer Cell Research
Lazertinib (YH25448) MOA：Targeting EGFR/MAPK Signaling Pathway for First-Line Treatment of EGFR-Mutated Advanced NSCLC